Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Steroid Withdrawal in Pediatric Kidney Transplant Recipients

This study has been terminated.
(Effective August 13, 2004: Unanticipated high incidence of post-transplant lymphoproliferative disorder)
Cooperative Clinical Trials in Pediatric Transplantation
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID) Identifier:
First received: August 29, 2001
Last updated: October 19, 2016
Last verified: October 2016